Circulating MicroRNA Signature for the Diagnosis of Very High-Risk Prostate Cancer*

doi 10.1201/9781003056713-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Jenny Stanford Publishing

Related search

Plasma microRNA Signature Is Associated With Risk Stratification in Prostate Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
2017English

Large-Scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

A Panel of microRNA Signature in Serum for Colorectal Cancer Diagnosis

Oncotarget
Oncology
2017English

Changes in Circulating microRNA Levels Associated With Prostate Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Oncogenic microRNA Signature for Early Diagnosis of Cervical Intraepithelial Neoplasia and Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Combined Chemohormonalradiation Treatment of Highand Very-High-Risk Non-Metastatic Prostate Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2017English

Circulating microRNA Testing for the Early Diagnosis and Follow-Up of Colorectal Cancer Patients

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2014English

Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy